ADVERTISEMENT

RSV vaccine candidate highly effective in older adults

Liz Scherer   |   Clinical Summary   |   23 February 2023
ADVERTISEMENT

Takeaway

  • Single-dose AS01 E -adjuvanted RSV prefusion F protein-based vaccine (RSVPreF3 OA) candidate is highly effective against respiratory syncytial virus (RSV)-related lower respiratory tract infection and severe disease in one season among adults aged 60 years and older,...

          

March Challenge

Ends in 4d 19h
left
right

Topic Challenges

left
right